Skip to content

Can a Relaxometer Improve Cognitive Impairment of Fibromyalgia Patients

Unknown statusNot applicableNCT04170387
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The aim of the study is to evaluate the differences in cognitive performance and quality of life, after a cycle of treatment with the relaxometer, between a group of patients affected by fibromyalgia and a control group.

Study details

Official title
Passive Movements of Fingers and Impact on Cognitive Impairment and Blurry Mind in Fibromyalgic Patients: Exploratory Study
Conditions
Interventions
  • Other: Relaxometer
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Start date
2019-12-15
Primary completion
2019-12-15
Sex
All
Age range
from 18 Years to 65 Years
Healthy volunteers
true
Results posted
No results posted in this snapshot
Total sites listed
0

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Fibromyalgic Syndrome diagnosed according to the criteria of American College of Rheumatology 2016 (ACR 2016) * moderate-severe cognitive impairment according to the Symptoms Severity Score (SS) * informed consent gathered Exclusion Criteria: * contraindication to passive handling of fingers (severe arthritis, fractures or unconsolidated traumatic outcomes, not healed wounds, finger amputations, contact allergies to substances contained in the relaxometer) * informed consent not gathered * drug addiction * brain stroke Withdrawal from study * withdrawal of informed consent * treatment non completed

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04170387